Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2005
03/31/2005WO2005028497A2 Receptor binding peptides derived from the sars s protein
03/31/2005WO2005028494A1 Process for producing 5'-phosphitylated monomer and h-phosphonate oligonucleotide derivative
03/31/2005WO2005027980A1 Rna interference for the treatment of gain-of-function disorders
03/31/2005WO2005027959A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization.
03/31/2005WO2005027848A2 Methods for screening osteogenic compounds targeting syk kinase and/or vav3 and uses of syk modulators and/or vav modulators
03/31/2005WO2005027844A2 Dna vaccine compositions and methods of use
03/31/2005WO2005027830A2 Chimeric transcription factor decoy oligonucleotides
03/31/2005WO2005027723A2 Real time assay for rotavirus
03/31/2005WO2005019259A3 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/31/2005WO2005009355A3 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
03/31/2005WO2004110371A3 Method for the treatment of malignancies
03/31/2005WO2004104224A3 Markers for lxr activation
03/31/2005WO2004093645A3 Tn5 transposase mutants and the use thereof
03/31/2005WO2004087062A3 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
03/31/2005WO2004063712A3 Methods for diagnosis and prognosis of cancer
03/31/2005WO2004058990A3 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
03/31/2005WO2004048522A3 Modulation of huntingtin interacting protein 2 expression
03/31/2005WO2004045547A3 Rnai-based sensors, caged interfering rnas, and methods of use thereof
03/31/2005WO2003099215A3 Antisense modulation of glucocorticoid receptor expression
03/31/2005WO2003054143A3 Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
03/31/2005WO2003044178A8 Hybrid oligonucleotide primers for amplification of dna and uses thereof
03/31/2005US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening
03/31/2005US20050070691 Polypeptides of moraxella (branhamella) catarrhalis
03/31/2005US20050070494 Transforming growth factor-beta response element decoys and methods
03/31/2005US20050070491 Immunostimulatory nucleic acid molecules
03/31/2005US20050070016 Which mimic activation domains; fusion proteins; binding proteins
03/31/2005US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin
03/31/2005US20050069976 Protein-coupled receptor
03/31/2005US20050069945 Human chemotactic cytokine I polypeptides
03/31/2005US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing
03/31/2005US20050069929 Methods and compositions for seamless cloning of nucleic acid molecules
03/31/2005US20050069928 Methods for synthesis of defined polynucleotides
03/31/2005US20050069924 Differentially methylated sequences in pancreatic cancer
03/31/2005US20050069921 Compositions, kits, and methods for stimulation of homologous recombination
03/31/2005US20050069916 Set of reporter signals use in detection of polymorphisms associated with metabolic and developmental disorders; multiplex detection and analysis of analytes and biomolecules
03/31/2005US20050069912 Energy transfer dyes with enhanced fluorescence
03/31/2005US20050069908 DNA polymerase compositions for quantitative PCR and methods thereof
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders.
03/31/2005US20050069875 Using CD109 region specific primer as tool in diagnosis, prevention and treatment of thrombocytopenia
03/31/2005US20050069873 Nucleotide sequences coding insulin like growth factor binding protein-3 (IGFBP-3) receptor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
03/31/2005US20050069870 Novel hepatitis C viral sequences for use as tool in detection, treatment and prevention of viral infection; immunotherapy; immunodiagnostics
03/31/2005US20050069869 Nucleotide sequences coding severe acute respiratory syndrome (SARS) spike glycoprotein for use as tool in development of immunoglobulins for prevention and treatment of respiratory system disorders; immunotherapy; imunodiagnostics
03/31/2005US20050069521 Enhancing the circulating half-life of interleukin-2 proteins
03/31/2005CA2579638A1 Rna interference targeting non-disease causing single nucleotide polymorphisms within a gene encoding a gain-of-function mutant huntingtin protein
03/31/2005CA2540103A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization
03/31/2005CA2539325A1 Consensus/ancestral immunogens
03/31/2005CA2539074A1 Campylobacter polypeptides and methods of use
03/31/2005CA2538840A1 Dna vaccine compositions and methods of use
03/31/2005CA2537085A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
03/30/2005EP1517912A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
03/30/2005EP1517910A1 Phosphoramidites for coupling oligonucleotides to (2 + 2) photoreactive groups
03/30/2005EP1517699A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
03/30/2005EP1517604A2 No-apical meristem proteins, polynucleotides and methods of use for same
03/30/2005EP1412413A4 Synthesis and use of organosilica particles
03/30/2005EP1248859B1 Method for synthesising and immobilising nucleic acids on a silanized solid support
03/30/2005EP1171632A4 Nucleic acid ligand inhibitors to dna polymerases
03/30/2005EP1019532B1 Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae
03/30/2005EP0928290B1 Oligoribonucleotides and ribonucleases for cleaving rna
03/30/2005CN1602361A Hybridization portion control oligonucleotide and its uses
03/30/2005CN1602207A Methods for inhibiting ocular processes
03/30/2005CN1600859A Meiosis gene of paddy, coded protein and application
03/30/2005CN1600858A SiRNA for restraining melanin, preparation method and application
03/30/2005CN1600789A Promotive factor for activating NF-kappa B and usage
03/30/2005CN1600788A Distinguishing gene for adjusting and controlling anti-oncogene p53 and usage
03/30/2005CN1194989C Novel human protein able to suppress cancer cell growth and its coding sequence
03/29/2005US6872809 Nucleoside derivatives
03/29/2005US6872710 Di(uridine 5′)-tetraphosphate and salts thereof
03/29/2005US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
03/29/2005US6872532 Method and kit for detecting white spot syndrome virus
03/29/2005US6872527 Storing preferential nucleotide sequences on solid matrix; obtain nucleic acid sample, incubate with solid matrix, join nucleic acids to to matrix, recover matrix
03/29/2005US6872523 Materials and methods for molecular detection of clinically relevant pathogenic fungal species
03/29/2005US6872393 Polyalkylene oxide-modified single chain polypeptides
03/29/2005CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate
03/29/2005CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate
03/26/2005CA2441695A1 Regulation of matrix metalloproteinases by psp94 family members
03/24/2005WO2005026392A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
03/24/2005WO2005026357A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells
03/24/2005WO2005026327A2 Biosynthetic gene cluster for leptomycins
03/24/2005WO2005026317A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3
03/24/2005WO2005026192A2 Hpv cd8+ t-cell epitopes
03/24/2005WO2005026187A1 Nucleoside or nucleotide having nonnatural base and use thereof
03/24/2005WO2005025497A2 Hpv cd8+ t-cell epitopes
03/24/2005WO2005025495A2 Methods and compositions for blocking progression of a disease state
03/24/2005WO2005025409A2 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms
03/24/2005WO2005010201A3 Methods and compositions for detecting nucleic acid sequences
03/24/2005WO2005001140A3 Methods and nucleic acids for the analysis of colon cell proliferative disorders
03/24/2005WO2005000215A3 Methods for treating pain
03/24/2005WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide
03/24/2005WO2004108079A3 Parkin-interacting proteins
03/24/2005WO2004104229A3 Internal control nucleic acid molecule for nucleic acid amplification systems
03/24/2005WO2004101766A3 Grp94-based compositions and methods of use thereof
03/24/2005WO2004092337A3 Promoting cardiac cell differentiation
03/24/2005WO2004084815A3 Virulence genes of h. pylori in gastric cancer
03/24/2005WO2004078941A3 Modulation of gene expression using dna-rna hybrids
03/24/2005WO2004071178A3 Annexin and p34 promoters and use in expression of transgenic genes in plants
03/24/2005WO2004069849A3 Bead emulsion nucleic acid amplification
03/24/2005WO2004053142A3 P53-associated parkin-like cytoplasmic protein, and related compositions and methods
03/24/2005WO2004048546A3 Methods for identifying risk of breast cancer and treatments thereof
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 899